Results 91 to 100 of about 4,717 (108)

2-Methoxyethanol: MAK-Begründung, Nachtrag. [PDF]

MAK Collect Occup Health Saf
Hartwig A, MAK Commission https://www.dfg.de/de/ueber-uns/gremien/senat/arbeitsstoffe/mitglieder.   +1 more
europepmc   +1 more source

1,3-Bis(hydroxymethyl)harnstoff: MAK-Begründung, Nachtrag. [PDF]

MAK Collect Occup Health Saf
Hartwig A, MAK Commission https://www.dfg.de/de/ueber-uns/gremien/senat/arbeitsstoffe/mitglieder.   +1 more
europepmc   +1 more source

[Anti-CD19 treatment: the new gold standard for IgG4-related diseases]. [PDF]

Z Rheumatol
Krusche M.
europepmc   +1 more source

Trimellitsäureanhydrid: MAK-Begründung, Nachtrag. [PDF]

MAK Collect Occup Health Saf
Hartwig A, MAK Commission .
europepmc   +1 more source

N,N-Bis(2-ethylhexyl)-((1,2,4-triazol-1-yl)methyl)amin: MAK-Begründung, Nachtrag.

MAK Collect Occup Health Saf
Hartwig A, MAK Commission.
europepmc   +1 more source

Statement of the Uterus Commission of the Gynecological Oncology Working Group (AGO) on Neoadjuvant Chemotherapy Prior to Definitive Radiochemotherapy in Patients with Locally Advanced Cervical Cancer. [PDF]

Geburtshilfe Frauenheilkd
Tempfer C, Fehm T, Vordermark D, Marnitz-Schulze S, Beckmann MW, Denschlag D, Brucker S, Wallwiener M, Eichbaum M, Ataseven B, Hillemanns P, für die Kommission Uterus der AGO .   +11 more
europepmc   +1 more source

N-Methylolchloracetamid: MAK-Begründung, Nachtrag. [PDF]

MAK Collect Occup Health Saf
Hartwig A, MAK Commissionhttps://www.dfg.de/de/ueber-uns/gremien/senat/arbeitsstoffe/mitglieder.   +1 more
europepmc   +1 more source